Riaz Ahmed Agha

Riaz Ahmed Agha

Auto-generated profile, based on publicly available information

Riaz Ahmed Agha

Premier Science

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2025 in Premier Journal of Science
Verified
Journal Article
Open access
RARiaz A. Agha
Riaz A. Agha
GMGinimol Mathew
Ginimol Mathew
RRRasha Rashid
Rasha Rashid
AKAhmed Kerwan
Ahmed Kerwan
AAAhmed Al-Jabir
Ahmed Al-Jabir
MAMaliha Agha
Maliha Agha
The use of AI in research and the literature is increasing. The need for transparency is clear. Here we present a guideline to transparently report the use of AI in any manuscript in general. The guideline items cover; declaration, purpose and scope, AI tools and configuration, data inputs and safeguards, human oversight and verification, bias, ethics and regulatory compliance and reproducibility and transparency. These items have been confirmed in a recent Delphi consensus exercise with high participation and agreement. This guide will evolve over time as technology, systems and behaviour evolve.

5 June 2025 in Premier Journal of Science
Verified
Journal Article
Open access
AKAhmed Kerwan
Ahmed Kerwan
AAAhmed Al-Jabir
Ahmed Al-Jabir
GMGinimol Mathew
Ginimol Mathew
CSCatrin Sohrabi
Catrin Sohrabi
RRRasha Rashid
Rasha Rashid
RARiaz A. Agha
Riaz A. Agha
INTRODUCTION Artificial intelligence (AI) is rapidly transforming healthcare and scientific publishing. Reporting guidelines need to be updated to consider this advance.The SCARE Guideline 2025 update introduces a new AI-focused domain to promote transparency, reproducibility, and ethical integrity in surgical case reports (SCAREs) involving AI. METHODS A Delphi consensus exercise was conducted to update the SCARE guidelines. A panel of 49 surgical and scientific experts was invited to rate proposed new items. In round 1, participants scored each item on a nine-point Likert scale and provided feedback. Items not meeting consensus were revised or discarded. RESULTS A 94% response rate occurred amongst participants (46/49) in the first round. Ratings were analyzed for agreement levels, and consensus was reached on all six proposed AI-related items. A revised SCARE checklist is presented, which incorporates these new AI-related items. Authors are now expected to disclose AI involvement in patient care and manuscript preparation, as exemplified by this article. CONCLUSION The SCARE 2025 guideline provides an up-to-date framework for SCAREs in the era of AI. Through a robust consensus process, we have added specific reporting criteria for AI to ensure that any use of AI in a case report is documented, explained, and discussed concerning bias and ethics. This update will help maintain the quality, transparency, and clinical relevance of case reports, ultimately improving their educational value and trustworthiness for the surgical community.

1 December 2011 in Journal of Surgical Research
Verified
Journal Article
Closed access
RARiaz Agha
Riaz Agha
RORei Ogawa
Rei Ogawa
GPGiorgio Pietramaggiori
Giorgio Pietramaggiori
DODennis P. Orgill
Dennis P. Orgill

2 February 2011 in Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
HBHina Bhutta
Hina Bhutta
RARiaz Agha
Riaz Agha
JWJoy Wong
Joy Wong
TTTjun Y. Tang
Tjun Y. Tang
YWYvonne G. Wilson
Yvonne G. Wilson
SWStewart R. Walsh
Stewart R. Walsh
Background: The systemic nature of atherosclerosis compromises medium-term survival following major vascular surgery. Neutrophil—lymphocyte ratio (NLR) is a simple index of systemic inflammatory burden which correlates with survival following percutaneous coronary intervention. Methods: Patients undergoing elective major vascular surgery in 2 tertiary vascular units were identified from prospectively maintained databases. Factors associated with 2-year mortality were assessed by univariate and multivariate analyses. Results: Over a 4-year period, 1021 patients underwent elective major vascular surgery (carotid endarterectomy, abdominal aortic aneurysm repair, lower limb revascularization). Two-year mortality was 11.2%. In multivariate analysis, preoperative NLR > 5 was independently associated with 2-year mortality (multivariate odds ratio [OR] 2.21; 95% confidence interval [CI] 1.22-4.01). Conclusion: Preoperative NLR identifies patients at increased risk of death within 2 years of major vascular surgery. This simple index may facilitate targeted preventive measures for high-risk patients.

1 December 2007 in International Journal of Surgery
Verified
Journal Article
Closed access
RARiaz Agha
Riaz Agha
DCDerek Cooper
Derek Cooper
GMGordon Muir
Gordon Muir
In order to examine the reporting quality of urological RCTs, the initial objectives of this study were to evaluate the degree to which RCTs involving urological surgical techniques (as the intervention) published in the years 2000-2003 complied with the CONSORT statement, and to assess trends and patterns of compliance. Following our initial findings in urology, we extended the methodology to a number of other specialties to assess whether our findings in urology could be generalised to other surgical disciplines. The Royal Society of Medicine (RSM) Library was commissioned to search the Medline and Cochrane databases for RCTs in compliance with the study inclusion criteria below. Additional analyses of five other specialties (non-urological trials: cardiovascular, gastrointestinal, hepatic, orthopaedic and vascular) were also made. For the non-urological trials, 15 English language trials (from each specialty) were randomly picked from a blast search conducted by the RSM for the year 2003. The RCTs were given a score out of 22, reflecting how many of the 22 CONSORT items were complied with (with each item being given equal weighting), this score was termed the "CONSORT score". Urology trials: In total 122 RCT abstracts were identified which met the inclusion criteria for this study. From these, 32 were excluded as they were follow-up studies, involved a virtual procedure or were a cost analysis, leaving 90 RCTs published across 35 different journals which were analysed (68.2%, 90/122). The average score of 11.1 for urological trials indicates that RCTs in our sample do not comply with the CONSORT statement. No trials reported how they implemented their randomisation process. Only 46% of RCTs stated that they had permission from an ethics review board, 20% had declared their sources of funding, 14% stated whether there were any conflicts of interest and only 1.1% stated their trial registry number. For non-urological studies, an average CONSORT score of 11.2 was obtained. Clinical research teams conducting RCTs in urology and other surgical disciplines demonstrate poor compliance with the CONSORT statement. We would recommend that trials should be registered at their outset and that urological and other surgical journals to consider supporting the CONSORT statement and to have compliance 'hard-wired' into their submission, editorial and peer-review processes. Since it seems the best researchers are unable to produce an RCT results which enable surgical techniques to be critically assessed, there is a need for education about the CONSORT statement and its importance at all levels of surgical training. We believe that an open debate is needed on the possible role of other research designs, such as tracker studies. Whether this study actually raises the question of how appropriate RCTs are to surgical techniques, we leave to the reader.

1 February 2015 in Journal of Plastic, Reconstructive & Aesthetic Surgery
Verified
Journal Article
Closed access
RARiaz A. Agha
Riaz A. Agha
AFAlexander J. Fowler
Alexander J. Fowler
CHChristian Herlin
Christian Herlin
TGTim E.E. Goodacre
Tim E.E. Goodacre
DODennis P. Orgill
Dennis P. Orgill